Status:

COMPLETED

Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness

Lead Sponsor:

University of California, San Diego

Collaborating Sponsors:

Veterans Medical Research Foundation

University of California

Conditions:

Bipolar Disorder

Schizophrenia

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

Approximately 60 chronic smokers with bipolar disorder, schizophrenia or schizoaffective disorder who are motivated to try to quit smoking will be randomized to receive smoking cessation treatment wit...

Detailed Description

This pilot feasibility trial is a Phase IV, 12-week, single center, randomized, double blind, parallel group comparison of low (0.5 mg twice daily with slower titration over one full week) versus stan...

Eligibility Criteria

Inclusion

  • 18-70 years of age
  • Outpatients with a DSM-V diagnosis of Bipolar Disorder or Schizophrenia Spectrum Disorder
  • Smoke at least 10 cigarettes per day and have an expired carbon monoxide (CO) breathalyzer of ≥ 10 ppm at screening and baseline visits
  • Are motivated to quit smoking
  • Have access to a mental health provider

Exclusion

  • Females who are pregnant, planning to become pregnant, or lactating
  • Test positive for any non-prescribed medications or illicit drugs
  • Have made a suicide attempt or engaged in self-mutilatory behavior in the past year
  • Meet criteria for another Substance Use Disorder in the past month
  • In the investigators' judgement, are either psychiatrically or medically unstable to safely participate
  • Are currently using any other form of treatment for smoking cessation

Key Trial Info

Start Date :

August 12 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 4 2022

Estimated Enrollment :

39 Patients enrolled

Trial Details

Trial ID

NCT04011280

Start Date

August 12 2019

End Date

March 4 2022

Last Update

June 22 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pacific Treatment & Research Center at UCSD

La Jolla, California, United States, 92093

Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness | DecenTrialz